Author Archives: april@madhedgefundtrader.com

When The Longship Everyone Abandoned Sets Sail

Let me tell you about the worst day I’ve had watching a biotech stock in years. August 19, 2025. Viking Therapeutics (VKTX) reported its oral VK2735 data, and the stock dropped 40% before I could finish my morning coffee. My phone exploded with panicked messages from people who’d clearly only read the headlines. “High discontinuation […]

Testimonial

I was a bit tentative about using actual portfolio numbers – but thought it may help readers understand you don’t need to be a billionaire to work with John Thomas. I am pleased to let you know that I have made money on Strategy (MSTR), Eli Lilly (LLY), and Amgen (AMGN) and clocked $529,000. Regarding […]

A Note on Assigned Options, or Options Called Away Updated

Last week, I received a surprise text from Interactive Brokers informing me that I had my short put options assigned or called away. I immediately fell down on your knees and thank my lucky stars. I just made the maximum possible profit for your position instantly. We have the good fortune to have three spreads […]

The European Dream

Silicon Valley is opening a new front across the Atlantic. Cementing American tech hegemony in Europe is a goal of Silicon Valley, and that couldn’t be more evident in a recent interview by the CEO of Palantir (PLTR), Alex Karp. Karp used his time to voice Europe’s “defeatist” bureaucracy and tech timidity. Remember, this is […]